GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast A/S (LTS:0QBO) » Definitions » Cyclically Adjusted PB Ratio

Coloplast A/S (LTS:0QBO) Cyclically Adjusted PB Ratio : 24.41 (As of May. 21, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Coloplast A/S Cyclically Adjusted PB Ratio?

As of today (2024-05-21), Coloplast A/S's current share price is kr848.60. Coloplast A/S's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was kr34.76. Coloplast A/S's Cyclically Adjusted PB Ratio for today is 24.41.

The historical rank and industry rank for Coloplast A/S's Cyclically Adjusted PB Ratio or its related term are showing as below:

LTS:0QBO' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 20.9   Med: 28.54   Max: 43.12
Current: 24.34

During the past years, Coloplast A/S's highest Cyclically Adjusted PB Ratio was 43.12. The lowest was 20.90. And the median was 28.54.

LTS:0QBO's Cyclically Adjusted PB Ratio is ranked worse than
97.65% of 469 companies
in the Medical Devices & Instruments industry
Industry Median: 2.14 vs LTS:0QBO: 24.34

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Coloplast A/S's adjusted book value per share data for the three months ended in Mar. 2024 was kr71.987. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr34.76 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Coloplast A/S Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Coloplast A/S's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast A/S Cyclically Adjusted PB Ratio Chart

Coloplast A/S Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.49 37.39 35.32 24.27 22.77

Coloplast A/S Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.21 27.01 22.77 23.07 26.70

Competitive Comparison of Coloplast A/S's Cyclically Adjusted PB Ratio

For the Medical Instruments & Supplies subindustry, Coloplast A/S's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coloplast A/S's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast A/S's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Coloplast A/S's Cyclically Adjusted PB Ratio falls into.



Coloplast A/S Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Coloplast A/S's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=848.60/34.76
=24.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coloplast A/S's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Coloplast A/S's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=71.987/118.4000*118.4000
=71.987

Current CPI (Mar. 2024) = 118.4000.

Coloplast A/S Quarterly Data

Book Value per Share CPI Adj_Book
201406 25.756 99.700 30.587
201409 29.841 99.700 35.438
201412 25.623 99.400 30.521
201503 30.743 100.200 36.327
201506 27.409 100.300 32.355
201509 22.266 100.200 26.310
201512 19.049 99.800 22.599
201603 23.164 100.200 27.371
201606 21.248 100.600 25.008
201609 23.935 100.200 28.282
201612 19.851 100.300 23.433
201703 23.870 101.200 27.927
201706 23.343 101.200 27.310
201709 28.050 101.800 32.624
201712 22.176 101.300 25.919
201803 25.351 101.700 29.514
201806 24.554 102.300 28.418
201809 30.221 102.400 34.943
201812 24.434 102.100 28.335
201903 29.055 102.900 33.432
201906 28.002 102.900 32.220
201909 32.544 102.900 37.446
201912 25.620 102.900 29.479
202003 30.963 103.300 35.489
202006 29.909 103.200 34.314
202009 34.822 103.500 39.835
202012 27.094 103.400 31.024
202103 32.572 104.300 36.975
202106 32.557 105.000 36.712
202109 38.383 105.800 42.954
202112 30.162 106.600 33.501
202203 34.778 109.900 37.468
202206 34.266 113.600 35.714
202209 39.057 116.400 39.728
202212 27.813 115.900 28.413
202303 31.331 117.300 31.625
202306 28.908 116.400 29.405
202309 77.001 117.400 77.657
202312 67.275 116.700 68.255
202403 71.987 118.400 71.987

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Coloplast A/S  (LTS:0QBO) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Coloplast A/S Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Coloplast A/S's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Coloplast A/S (LTS:0QBO) Business Description

Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast A/S (LTS:0QBO) Headlines

No Headlines